Gemita 200 mg Injection (Gemcitabine)
| Active Ingredient | Gemcitabine |
|---|---|
| Indication: | Ovarian cancer, Head and neck cancer, Cervical cancer |
| Manufacturer: | Fresenius Kabi India Pvt.Ltd. |
| Packaging | 1 Injection in 1 vial |
| Strength | 200mg |
| Delivery Time | 6 To 15 days |
Gemita 200mg Injection contains Gemcitabine, a cytotoxic chemotherapy agent used to treat several types of cancer, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer. Gemcitabine belongs to the antimetabolite class, working by disrupting the DNA replication of rapidly dividing cancer cells, thereby slowing or stopping tumor growth.
This lower-dose formulation of 200 mg is typically used for dose adjustments, combination regimens, or in patients requiring reduced-intensity treatment. It is administered intravenously (IV) in a clinical setting under oncologist supervision, often as part of a broader chemotherapy schedule.








There are no reviews yet.